Phase Ib/II study of ALT-803 in combination with gemcita

Project: Research project

Project Details

Description

Phase Ib/II study of ALT-803 in combination with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer
StatusFinished
Effective start/end date10/1/159/30/19

Funding

  • ALTOR BIOSCIENCE LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.